KRYS vs MSFT: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Microsoft Corp in 2026
KRYS
Krystal Biotech Inc
$267.41
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | KRYS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $7.62B | N/A | KRYS |
| P/E Ratio | 37.87 | 24.04 | MSFT |
| EPS (TTM) | $6.84 | $15.99 | MSFT |
| Revenue Growth | 0.2% | 0.2% | KRYS |
| Gross Margin | 94.1% | 68.6% | KRYS |
Analyze KRYS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or MSFT a better investment?
Comparing KRYS and MSFT: Krystal Biotech Inc has a market cap of $7.62B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and MSFT?
KRYS (Krystal Biotech Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (24.0x vs 37.9x).
Which is growing faster: KRYS or MSFT?
KRYS has higher revenue growth at 0.2% vs 0.2% for MSFT.
Which company is more profitable: KRYS or MSFT?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 68.6% for MSFT.
Which is the larger company: KRYS or MSFT?
Krystal Biotech Inc (KRYS) is larger with a market cap of $7.62B compared to N/A for MSFT.
Should I buy KRYS or MSFT in 2026?
Both KRYS and MSFT have investment merit. KRYS trades at $267.41 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and MSFT stock?
Key differences: Market Cap ($7.62B vs N/A), P/E Ratio (37.9x vs 24.0x), Revenue Growth (0.2% vs 0.2%), Gross Margin (94.1% vs 68.6%).